Detection of anti-infliximab antibodies is of limited value to predict acquired drug resistance to infliximab in rheumatoid arthritis

被引：0
|
作者：
Finckh, Axel [1 ]
Dudler, Jean [2 ]
Wennelinger, Felix [3 ]
Ciurca, Adrian [4 ]
Gabay, Cem [1 ]
Bas, Sylvette [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Univ Lausanne Hosp, Lausanne, Switzerland
[3] Univ Hosp Bern, CH-3010 Bern, Switzerland
[4] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S777 / S777
页数：1
相关论文
共 50 条
  • [31] Anti-infliximab antibodies in patients with an infusion related allergic response to infliximab.
    Wolbink, G
    de Groot, E
    Lems, W
    Dijkmans, B
    Nurmohamed, M
    Tak, PP
    Voskuyl, A
    Aarden, L
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S326 - S326
  • [32] PROLONGING BETWEEN-INFUSIONS INTERVAL IS ASSOCIATED WITH POSITIVITY TO ANTI-INFLIXIMAB ANTIBODIES IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS
    Verdet, M.
    Guillou, C.
    Golinski, M. -L.
    Hiron, M.
    Jouen, F.
    Boyer, O.
    Lequerre, T.
    Vittecoq, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 871 - 871
  • [33] ESTABLISHING CUT-OFF OF INFLIXIMAB AND ANTI-INFLIXIMAB ANTIBODY LEVELS USING A COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, D.
    De la Torre, I.
    Martinez, L.
    Nieto, J.
    Llinares, F.
    Rosas, J.
    Gonzalez, C.
    Monteagudo, I.
    Lopez-Longo, J.
    Montoro, M.
    Carreno, L.
    Valor, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 237 - 237
  • [34] ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB
    Kosmac, M.
    Toplak, N.
    Simonini, G.
    Cimaz, R.
    Serbec, V. Curin
    Avcin, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 255 - 255
  • [35] Development of anti-infliximab antibodies increases infliximab clearance in chronic inflammatory bowel disease
    Ternant, D.
    Aubourg, A.
    Magdelaine-Beuzelin, C.
    Degenne, D.
    Watier, H.
    Picon, L.
    Paintaud, G.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 23 - 23
  • [36] Quantum blue anti-infliximab: development and evaluation of a point of care rapid test for measuring anti-infliximab antibodies in human serum
    Bantleon, F.
    Schneider, M.
    Ricken, B.
    Velayutham, S.
    Trapani, D.
    Afonso, J.
    Magro, F.
    Abel, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S194 - S195
  • [37] Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy
    Bar-Yoseph, H.
    Levhar, N.
    Selinger, L.
    Manor, U.
    Yavzori, M.
    Picard, O.
    Fudim, E.
    Kopylov, U.
    Eliakim, R.
    Ben-Horin, S.
    Chowers, Y.
    Ungar, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 212 - 218
  • [38] Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
    Svenson, M.
    Geborek, P.
    Saxne, T.
    Bendtzen, K.
    RHEUMATOLOGY, 2007, 46 (12) : 1828 - 1834
  • [39] Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis
    Siljehult, F.
    Arlestig, L.
    Eriksson, C.
    Rantapaa-Dahlqvist, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (05) : 345 - 350
  • [40] Comparison of drug tolerant assays for the measurement of bound anti-infliximab antibodies in patient serum
    Sam, Melissa
    Cameron, Karla
    Ward, Mark
    Rexhepi, Therese
    Gu, Bonita
    Haifer, Craig
    Connor, Susan J.
    Harman, David
    Donald, William
    Toong, Catherine
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 150 - 150
12345